COVID-19: Investigational Drugs and Other Therapies


Novel (COVID-19 or 2019-nCoV or SARS-CoV-2), which abruptly arose in December 2019 is as yet frequenting the whole human race and has influenced not just the medical care framework yet additionally the worldwide financial equilibriums. Corona virus was immediately assigned as a worldwide pandemic by the World Health Organization as there have been about 98.0 million affirmed cases and about 2.0 million affirmed passing, as of January 2021. In spite of the fact that, our comprehension of COVID-19 has altogether expanded since its episode, and various treatment draws near and pharmacological mediations have been tried or are right now being worked on to alleviate its danger factors.



As of late, some antibody applicants appeared around 95% clinical viability, and now accepting crisis use endorsements in various nations. US FDA as of late endorsed BNT162 and mRNA-1273 immunizations created by Pfizer/BioNTech and Moderna Inc. for crisis use and immunization in the USA. In this audit, we present a compact outline of the SARS-CoV-2 infection structure, atomic systems of contamination, COVID-19 the study of disease transmission, finding, and clinical appearances. We moreover arrange distinctive treatment methodologies and clinical preliminaries started after the pandemic flare-up, in light of viral contamination and replication components. Moreover, we surveyed the novel pharmacological mediation approaches and antibody improvement systems against COVID-19. We guess that the current pandemic crisis will trigger itemized investigations of Covids, their component of contamination, advancement of efficient medication repurposing approaches, and novel medication disclosures for current and future pandemic episodes.



 


  • SARS-CoV-2 Virus Structure and Integration
  • SARS-CoV-2 Virus Receptor Mechanism
  • Clinical Manifestation
  • Binding Antibody Detection Methods
  • Potential Treatment Strategies

Related Conference of COVID-19: Investigational Drugs and Other Therapies

August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
August 27-28, 2025

20th World Congress on Drug Formulation & Drug Delivery

Amsterdam, Netherlands
September 19-20, 2025

18th World Drug Delivery Summit

Paris, France
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 24-25, 2025

5th World Congress on Rare Diseases & Orphan Drugs

Aix-en-Provence, France
October 23-24, 2025

21st Annual Meet on Pharmaceutical Sciences

Aix-en-Provence, France
November 11-12, 2025

6th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, Aland Islands
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 21-22, 2026

8th International Conference and Exhibition on Pain Management

Aix-en-Provence, France

COVID-19: Investigational Drugs and Other Therapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in